Indication

Ecthyma gangrenosum

Ecthyma gangrenosum is a rare, severe cutaneous manifestation typically associated with systemic bacteremia, classic to *Pseudomonas aeruginosa* infection, though occasionally caused by other opportunistic pathogens. Read more about Ecthyma gangrenosum

22 drugs 13 manufacturers

Advertisement

Drugs that treat it

Common Ecthyma gangrenosum therapies.

Showing 1–9 of 22 drugs

CEFTAZIDIME

BETA-LACTAMS·MENINGOCOCCAL MENINGITIS·+67
SAGENT PHARMACE
Filter & compare in the drug finder →Opens the drug finder with Ecthyma gangrenosum preselected.

News & literature

Coming soon

Related codes

Coming soon
Coming soon

About Ecthyma gangrenosum.

Ecthyma gangrenosum is a rare, severe cutaneous manifestation typically associated with systemic bacteremia, classic to *Pseudomonas aeruginosa* infection, though occasionally caused by other opportunistic pathogens.

It predominantly affects the integumentary system of severely immunocompromised, neutropenic, or critically ill patients.

Pathophysiologically, hematogenous bacterial seeding leads to perivascular invasion of dermal and subcutaneous blood vessels, resulting in necrotizing vasculitis, secondary thrombosis, and localized tissue infarction.

Clinically, the condition manifests as painless erythematous macules or hemorrhagic bullae that rapidly progress into painless, punched-out necrotic ulcers covered by a central black eschar with an erythematous rim.

Personalize your experience

Follow Ecthyma gangrenosum and get updates as they land.

Create a free account

Follow an indication and get alerts when its drugs, labels, or guidelines change

Save any drug on this page to your favorites, synced across devices

AI-curated peer-reviewed research, summarized for your specialty

A morning digest of indication-relevant updates, when you want it